Smooth muscle cell (SMC) proliferation is a common response to vascular stress and a central feature in vascular diseases, such as atherosclerosis, restenosis and allograft vasculopathy. Among the variety of signaling pathways implicated in stress-induced SMC proliferation, oxidative stress and the sphingolipid pathway play a critical role. The molecular link between reactive oxygen species and the activation of the sphingolipid pathway is only partly understood. This study was carried out to investigate the role of the sphingolipid pathway in the mitogenic signaling elicited by of H2O2 in SMC.
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Low concentration of H2O2 triggered SMC proliferation through a signaling pathway involving the activation of MMP2 metalloprotease, and neutral sphingomyelinase-2 (nSMase2). Inhibition of MMP2 by Batimastat, a broad-speciÀ city MMP inhibitor, or the defect of MMP2-/-(À broblasts from MMP2 deÀ cient mice) blocked the H2O2-induced activation of nSMase2 and DNA synthesis, suggesting that all this enzyme activity is dependent on MMP2 activation. The genetic defect of nSMase2 (À broblasts from nSMase2-deÀ cient fro/ fro mice), and the use of nSMase2 speciÀ c siRNA did not inhibit the H2O2-induced activation of MMP2, but blocked the DNA synthesis.
In conclusion, these data shed light on a novel mechanism of stress-induced mitogenic response to low concentration of H2O2, involving the sequential action of MMP2 and nSMase2 with possible consequences under conditions leading to increased oxidative stress in the vascular wall. Objectives -Smooth muscle cell (SMC) proliferation is a major feature in atherosclerosis, since it contributes to the formation of the À brous cap, thus to plaque stability, but also to arterial stenosis and post-angioplasty restenosis. Among the various mitogenic signaling pathways involved in SMC proliferation, the mTOR pathway regulates both the cell cycle and cell growth. Resveratrol, a polyphenolic compound from grapes and red wine, has potential anti-atherogenic and anti-cancer properties. This work was designed to investigate the activation of the mTOR pathway by the proatherogenic oxidized LDL (oxLDL) in SMC, and the potential inhibitory effect of resveratrol.
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RESVERATROL INHIBITS THE MTOR MITOGENIC SIGNALING EVOKED BY OXIDIZED LDL IN SMOOTH MUSCLE CELLS
Results -mTOR and its downstream target p70S6 kinase are phosphorylated and activated by mitogenic concentrations of oxLDL (50mug/ml), and are involved in SMC proliferation, as assessed by the inhibitory effect of the mTOR inhibitor rapamycin. The activation of mTOR signaling by oxLDL, requires the upstream activation of PI3K and Akt, as assessed by the inhibitory effect of the PI3K inhibitor Ly294002 on mTOR activation and DNA synthesis. Resveratrol blocked the oxLDL-induced phosphorylation and activation of the PI3K/Akt/mTOR/p70S6K pathway and strongly inhibited both the DNA synthesis and proliferation of SMC. This activity is independent of the anti-oxidant effect and of AMPK activation by resveratrol.
Conclusion -These data indicate that the mTOR pathway is activated by oxLDL via PI3K/PDK1/Akt, and is required for SMC proliferation. Resveratrol blocks speciÀ cally this pathway, thereby inhibiting oxLDL-induced SMC proliferation. These data highlight a new property for resveratrol that could contribute to the general anti-atherogenic properties of this polyphenol. Les microparticules cellulaires jouent un rôle clé dans le contrôle de l'homéostasie vasculaire. S'il est clairement établi qu'elles représentent des vecteurs d'information biologique à multiples facettes (coagulation, inÁ ammation, protéolyse), leur implication dans le contrôle de la génération de plasmine n'a pas été documentée à ce jour.
E014
GENERATION DE PLASMINE PAR LES MICROPARTICULES ENDOTHELIALES : UN NOUVEAU MECANISME DANS LA REGULATION DES ACTIVITES PROTEOLYTIQUES DE L'ENDOTHELIUM
Notre travail a montré que les microparticules endothéliales (MPE) représentent des surfaces biologiques capables d'activer le plasminogène en plasmine grâce à l'expression du système de l'urokinase (uPA) et de son récepteur (uPAR). Cette activité est saturable et spéciÀ que comme l'indique l'inhibition de la formation de plasmine par l'acide ε-aminocaproïque et la carboxypeptidase B. Elle est ampliÀ ée par la capacité des MPE à lier de l'uPA exogène sur l'uPAR. Une partie de la plasmine formée, reste liée à la surface des MPE, ce qui protège cette enzyme de ses inhibiteurs physiologiques. De manière intéressante, cette activité varie en fonction de l'origine anatomique des cellules endothéliales, traduisant ainsi l'expression hétérogène du système uPA/uPAR le long de l'arbre vasculaire.
La génération de plasmine induite par les MPE module la capacité des progéniteurs à former des tubes vasculaires dans une matrice
